COVID Anti-Viral Pill (Dated March 28, 2022)

The province is clarifying the requirement for the COVID-19 anti-viral pill.

The Department of Health and Community Services says the pill Paxlovid, may be an option for those who are within five days of symptom onset and have received a positive test, either rapid or PCR.

The person must also be moderately to severely immunocompromised and not expected to mount an adequate immune response regardless of vaccine status.

It’s also for individuals over 80 who have to receive the full course of COVID-19 vaccine, or under vaccinated-individuals over 60 living in remote-communities, long-term care settings, or indigenous communities.

The department says the province is targeted to receive 14,000 treatment courses of Paxlovid, so they have to prioritize where it is used at this time.